# Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain

> **NIH NIH R01** · UNIVERSITY OF CALIFORNIA-IRVINE · 2021 · $79,881

## Abstract

Supplement Project Abstract Statement
It is included with the supplement research plan

## Key facts

- **NIH application ID:** 10452913
- **Project number:** 3R01DE029202-01S1
- **Recipient organization:** UNIVERSITY OF CALIFORNIA-IRVINE
- **Principal Investigator:** ZHIGANG David LUO
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $79,881
- **Award type:** 3
- **Project period:** 2021-09-01 → 2022-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10452913

## Citation

> US National Institutes of Health, RePORTER application 10452913, Validation of blocking TSP4/Cava2d1 interaction as a new target for neuropathic pain (3R01DE029202-01S1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10452913. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*